Literature DB >> 19153364

Pityriasis rubra pilaris responding rapidly to adalimumab.

Hobart W Walling, Brian L Swick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19153364     DOI: 10.1001/archdermatol.2008.527

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  3 in total

1.  Ustekinumab as an alternative treatment option for chronic pityriasis rubra pilaris.

Authors:  Mudit Chowdhary; Ulysses Davila; David J Cohen
Journal:  Case Rep Dermatol       Date:  2015-03-17

Review 2.  Management of refractory pityriasis rubra pilaris: challenges and solutions.

Authors:  Gaia Moretta; Erika V De Luca; Alessandro Di Stefani
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-11-09

3.  A case of classic adult pityriasis rubra pilaris successfully treated with a combination of acitretin and ustekinumab: A case report.

Authors:  Celina DeBiasio; Janelle Cyr; Yasmine Ayroud; Steven J Glassman
Journal:  SAGE Open Med Case Rep       Date:  2022-04-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.